Literature DB >> 23212354

[Pathogenesis of retinopathy of prematurity].

A Stahl1, W A Lagrèze, H T Agostini.   

Abstract

Retinopathy of prematurity (ROP) is a complex disease with a multifactorial pathogenetic cascade that is still only partially understood. Important pathogenetic factors are gestational age at birth and birth weight. Potent postnatal factors are exposure to supplemental oxygen, slow weight gain and expression of angiogenic growth factors. Some of these crucial aspects of ROP pathogenesis will be discussed in this article and put into clinical context. With the introduction of intravitreal anti-VEGF (vascular endothelial growth factor) treatment into ROP therapy, the pathomechanistic role of VEGF in ROP deserves a special focus. Apart from VEGF, other factors will be discussed that may precede VEGF upregulation and thus may represent targets for an earlier and potentially protective intervention. Among these insulin-like growth factor 1 (IGF-1) appears to be most prominent. Finally, factors such as postnatal weight gain will be discussed in light of their potential role as screening parameters and their ability to predict ROP severity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23212354     DOI: 10.1007/s00347-012-2616-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  41 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 2.  Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.

Authors:  Andreas Stahl; Tim U Krohne; Przemyslaw Sapieha; Jing Chen; Ann Hellstrom; Emily Chew; Frank G Holz; Lois E H Smith
Journal:  Br J Ophthalmol       Date:  2011-03-18       Impact factor: 4.638

3.  Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy.

Authors:  Andreas Stahl; Jing Chen; Przemyslaw Sapieha; Molly R Seaward; Nathan M Krah; Roberta J Dennison; Tara Favazza; Felicitas Bucher; Chatarina Löfqvist; Huy Ong; Ann Hellström; Sylvain Chemtob; James D Akula; Lois E H Smith
Journal:  Am J Pathol       Date:  2010-11-05       Impact factor: 4.307

4.  Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity.

Authors:  D K Wallace; J A Kylstra; S J Phillips; J G Hall
Journal:  J AAPOS       Date:  2000-12       Impact factor: 1.220

5.  Predicting proliferative retinopathy in a Brazilian population of preterm infants with the screening algorithm WINROP.

Authors:  Anna-Lena Hård; Chatarina Löfqvist; Joao Borges Fortes Filho; Renato Soibelmann Procianoy; Lois Smith; Ann Hellström
Journal:  Arch Ophthalmol       Date:  2010-11

6.  Serum levels of IGF1 are a useful predictor of retinopathy of prematurity.

Authors:  A Pérez-Muñuzuri; J R Fernández-Lorenzo; M L Couce-Pico; M J Blanco-Teijeiro; J M Fraga-Bermúdez
Journal:  Acta Paediatr       Date:  2010-01-18       Impact factor: 2.299

7.  Weight gain measured at 6 weeks after birth as a predictor for severe retinopathy of prematurity: study with 317 very low birth weight preterm babies.

Authors:  Joao Borges Fortes Filho; Pedro P Bonomo; Mauricio Maia; Renato S Procianoy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-04       Impact factor: 3.117

8.  Oxygen-induced retinopathy in the mouse.

Authors:  L E Smith; E Wesolowski; A McLellan; S K Kostyk; R D'Amato; R Sullivan; P A D'Amore
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

9.  Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

Authors:  E A Pierce; R L Avery; E D Foley; L P Aiello; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

10.  Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.

Authors:  Kip M Connor; John Paul SanGiovanni; Chatarina Lofqvist; Christopher M Aderman; Jing Chen; Akiko Higuchi; Song Hong; Elke A Pravda; Sharon Majchrzak; Deborah Carper; Ann Hellstrom; Jing X Kang; Emily Y Chew; Norman Salem; Charles N Serhan; Lois E H Smith
Journal:  Nat Med       Date:  2007-06-24       Impact factor: 53.440

View more
  3 in total

1.  Intravitreal vascular endothelial growth factor.

Authors:  Thomas Bertelmann; Stephan Schulze; Reka Bölöni; Walter Sekundo; Sebastian Irle; Thomas Stief; Stefan Mennel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-04       Impact factor: 3.117

2.  [Retinopathy of prematurity : Current developments in therapy and epidemiology].

Authors:  T U Krohne
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

3.  Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity.

Authors:  Xiu-Juan Li; Xiao-Peng Yang; Shuang Sun; Xiao-Bei Lyu; Heng Jia
Journal:  Chin Med J (Engl)       Date:  2016-12-05       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.